Demonstrates a LAMP assay detecting E198A-type resistant populations in C. monteithiana, suggesting a valuable tool for management.
The E198A (GAG→GCG) mutation at codon 198 of the β-tubulin gene confers high levels of resistance to methyl benzimidazole carbamate (MBC) fungicides in Clarireedia monteithiana worldwide. Early detection of E198A-type resistant populations is therefore essential for effective dollar spot management. In this study, we developed a rapid loop-mediated isothermal amplification (LAMP) assay for detecting MBC-resistant C. monteithiana. Optimal amplification occurred at 64°C for 60 min, and positive reactions were readily identified by a distinct purple-to–sky-blue color change using hydroxynaphthol blue (HNB) as the indicator. The selected primer set specifically distinguished E198A isolates from wild-type isolates, F200Y mutants, and closely related fungal species. The assay exhibited a detection limit of 2 × 10⁴ copies, reflecting a 100-fold higher sensitivity than conventional PCR. In host inoculation assays, the LAMP method achieved an accuracy of 95.83–96.78% across two experimental groups under near-field conditions, whereas PCR produced successful amplification for only 124 of 140 samples (88.57%). Collectively, these results demonstrate that the developed LAMP assay provides a rapid, sensitive, and robust tool for monitoring E198A-type MBC-resistant isolates and offers substantial value for the early detection and management of dollar spot disease.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: